Integrated Platform Drug Discovery and Development Companies – Part 2

Integrated Platform Drug Discovery and Development Companies – Part 2

Publication date: Oct 08, 2019

Recently there has been some attempt to amalgamate platform technologies within start-up and earlystage drug discovery and development companies to increase drug candidate pipeline numbers. This strategy does not come without risks, but has quietly been implemented by a number of platform-drug discovery and development (PD3) companies. This episode, part 2 explores this issue and use Moderna Therapeutics as our case study to highlight the limitations and potential impact on company valuation of such an integrated approach. Original article by Dr Urban A. Kiernan and Dr Stephen Naylor If you’d like to view the original article then follow the link below: https://www.ddw-online.com/business/p322578-emerging-paradigm-of-integrated-platform-drug-discovery-and-development-companies.html You can also download the original article pdf here: https://www.ddw-online.com/media/32/133163/(4)-emerging-paradigm-of-integrated-platform-drug-discovery.pdf For more information on Drug Discovery World, head to: https://www.ddw-online.com

Concepts Keywords
Alexia Technology assimilation
Antibodies Pharmaceutical sector
Assimilation Chemical instructions
Associative Technology development
AstraZeneca Drug technology
Barf Start-up
Bat Potential product
Bay Social media
Biotech Pharmaceuticals
Blind Faith Therapeutic drug products
Blood Moronic products
Boston Rare diseases
Brie TB
Business Model Heart disease
Cambridge Precision cancer
Cancer Viral diseases
Caustic Orphan disease
CEO Alexia
Clinical Trial Different cancers
Clinical Trials Diabetes
Computer Code Therapies indistinct disease
Conservative Heart failure
DARPA Certain viral infections
Dhe Stem cell therapy
Diabetes Gene therapy
Double Blind Drug therapies
Drug Development Musicians
Drug Discovery Health
Earthsea Moderna
Ego AstraZeneca
Emerald Madonna
Enlightenment Drug discovery
Entrepreneur Cell therapy
Equity Antibodies
Evolution GPS
FDA Pdf
Federal Grant Funding Drug technology
Force Gene therapy
Forenza Drug Discovery
France Platform technologies
Frequency Madonna technology
GPS
Harvard University
Heart Failure
Horizon
Immune System
Immunity
Infectious Disease
Invisibility Cloak
Japan
Jealousy
Lipid
Liver
Madonna
Merck
Mire
Molecule
Mork
Nano Particle
Nanoparticle
Ney
Oncology
Orphan Drug
Paradigm
Patent
Pharmaceutical
Pharmaceutical Companies
Pharmaceutical Company
Pharmaceuticals
Pipeline
Placebo
Plague
Plato
Podcast
Preferred Equity
Prophylactic
Protein
Radio Station
Receptors
Robert Langer
Roller Coaster
RPG
Seed Funding
Siri
Skepticism
Social Media
Staff Turnover
Stealth Mode
Theranos
Trophic
Trough
TTP
Twitter
Vaccine
Viral
Waas
War
Zika Virus

Semantics

Type Source Name
disease MESH Development
drug DRUGBANK Coenzyme M

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *